Brief: Lansen Pharmaceutical Unit Enters Shareholders' Loan Deal With CI Biotechnology & Other Co
15/12/2021 10:35
Dec 15 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* UNIT ENTERED INTO SHAREHOLDERS' LOAN AGREEMENT WITH CI
BIOTECHNOLOGY AND NATURAL DAILYHEALTH
* AGGREGATE PRINCIPAL AMOUNT UP TO US$3.3 MILLION & US$7.6
MILLION
RESPECTIVELY
* DEAL TO PROVIDE SHAREHOLDER LOAN TO NATURAL DAILYHEALTH
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year